- Home
- AVX vs TLPH Comparison
AVX vs TLPH Comparison
Compare AVX & TLPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | AVX | TLPH |
|---|---|---|
| Founded | 2017 | 2005 |
| Country | Canada | United States |
| Employees | 7 | N/A |
| Industry | Metal Fabrications | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 47.2M | 42.3M |
| IPO Year | N/A | 2010 |
Fundamental Metrics
Financial Performance| Metric | AVX | TLPH |
|---|---|---|
| Price | $5.57 | $1.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 277.4K | 180.3K |
| Earning Date | 05-15-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $2,151,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.35 | $0.38 |
| 52 Week High | $6.25 | $1.57 |
Technical Indicators
Market Signals| Indicator | AVX | TLPH |
|---|---|---|
| Relative Strength Index (RSI) | 91.85 | 76.20 |
| Support Level | $0.50 | $1.01 |
| Resistance Level | N/A | $1.44 |
| Average True Range (ATR) | 0.24 | 0.06 |
| MACD | 0.63 | 0.03 |
| Stochastic Oscillator | 88.55 | 100.00 |
Price Performance
Historical ComparisonAbout AVX Avax One Technology Ltd.
AVAX One Technology Ltd is a digital infrastructure company focused on digital asset and computing infrastructure. The Company builds modular data centers in regions with access to energy resources, using behind-the-meter generation and microgrid design to provide compute capacity for AI and high-performance computing (HPC) workloads. In addition, the company mines Bitcoin in Alberta and Ohio, operating at a hashrate of approximately 300 PH/s. The Company also maintains an Avalanche digital asset treasury, accumulating AVAX and generating onchain yield through native staking and ecosystem participation.
About TLPH Talphera Inc.
Talphera Inc. is a pharmaceutical company focused on the development and commercialization of therapies for use in medically supervised settings. The Company's nafamostat product candidates include Niyad and LTX-608. Its portfolio consists of nafamostat product candidates and pre-filled syringe product candidates.